Loading...
Loading...
Among the 8 tracked institutional investors we monitor, ADCT (ADC THERAPEUTICS SA) is held with a combined value of $61.56M across 16,481,356 shares. The largest holder is BlackRock, Inc. with a position worth $23.44M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 5 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$61.56M
Total Shares Held
16,481,356
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $23.44M | 0.00% | +15.2% |
| 2 | Point72 Asset Management, L.P. | $12.78M | 0.02% | -32.0% |
| 3 | MILLENNIUM MANAGEMENT LLC | $12.20M | 0.01% | +890.8% |
| 4 | STATE STREET CORP | $5.87M | 0.00% | +11.3% |
| 5 | VANGUARD GROUP INC | $3.99M | 0.00% | New |
| 6 | CITADEL ADVISORS LLC | $1.50M | 0.00% | +28.8% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | $1.12M | 0.00% | New |
| 8 | FMR LLC | $647.54K | 0.00% | +29.1% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of ADCT with a position worth $23.44M, representing 0.00% of their portfolio. In total, 8 institutional investors hold ADCT with a combined value of $61.56M.
In the most recent quarter, 2 funds opened a new position in ADCT. Additionally, 5 increased their holdings and 1 reduced their positions.
Institutional investors hold $61.56M worth of ADCT stock across 8 positions. The largest institutional holder is BlackRock, Inc. with $23.44M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ADCT, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ADCT positions.